English
Procter & Gamble Health Q4 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,887.30
-58.35 (-0.98%)
-58.35 (-0.98%)Volume230.00
Updated: Wed 12 Nov, 2025 | 15:10:59
NSE
5,897-50.00 (-0.84%)
-50.00 (-0.84%)Volume8.13 K
Updated: Wed 12 Nov, 2025 | 15:00:24
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Procter & Gamble Health Q4 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 25 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 262.98 | 235.44 | 37.05% |
| Depreciation/ Amortization | 7.16 | 5.37 | 4.68% |
| Operating Income | 20.90 | 75.55 | -65.51% |
| Net Income | 16.78 | 61.18 | -63.96% |
| Other Operating Expenses Total | 107.83 | 82.56 | 71.92% |
| Net Income Before Taxes | 22.83 | 78.53 | -63.60% |
| Total Revenue | 283.88 | 310.99 | 12.44% |
| Selling/ General/ Admin Expenses Total | 48.63 | 48.79 | 0.35% |
| Diluted Normalized EPS | 19.03 | 36.69 | -32.03% |